PsA Patients | Total number (%) |
---|---|
Gender, female | 86 (68.3) |
Gender, male | 40 (31.7) |
Age, years ± SD | 56.5 ± 11.4 |
BMI, value ± SD | 26.7 ± 5.1 |
Cardiovascular Diseasesa | 40 (31.8) |
Hypertension | 27 (21.4) |
Metabolic Diseasesb | 32 (25.4) |
Obesity | 23 (18.3) |
Diabetes type II | 12 (9.5) |
Depression/Anxiety Disorder | 18 (14.3) |
Neoplastic Diseasesc | 7 (5.6) |
Other Comorbiditiesd | 98 (77.8) |
Peripheral PsA | 124 (98.4) |
Axial PsA | 54 (42.9) |
Enthesitis | 69 (54.8) |
Dactylitis | 30 (23.8) |
Skin | 78 (61.9) |
Nails | 44 (34.9) |
Uveitis (ever) | 6 (4.8) |
IBD (ever) | 6 (4.8) |
DAPSA at baseline, mean ± SD | 27.7 ± 10.0 |
ASDAS-CRP at baselinee, mean ± SD | 2.65 ± 0.69 |
Disease Duration, months median (IQR) | 92 (45–177) |